{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:18:56Z","timestamp":1789726736988,"version":"4.0.1"},"reference-count":50,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Information from comparative proteome analysis of\n            <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n            and\n            <jats:italic>Mycobacterium bovis<\/jats:italic>\n            bacillus Calmette-Gue\u0301rin (BCG) principally allows prediction of potential vaccine candidates. Thirty-six\n            <jats:italic>M. tuberculosis<\/jats:italic>\n            DNA vaccine candidates identified by comparative proteome analysis were evaluated in the mouse model for protection against low-dose aerosol\n            <jats:italic>M. tuberculosis<\/jats:italic>\n            infection. We identified the DNA vaccine candidate Rv3407 as a protective antigen and analyzed putative major histocompatibility complex class I epitopes by computational predictions and gamma interferon Elispot assays. Importantly, we discovered that the DNA vaccine Rv3407 improved the efficacy of BCG vaccination in a heterologous prime-boost vaccination protocol. Our data demonstrate the rationale of a combination of proteomics, epitope prediction, and broad screening of putative antigens for identification of novel DNA vaccine candidates. Furthermore, our experiments show that heterologous prime-boost vaccination with a defined antigen boost \u201con top\u201d of a BCG primer provides superior protection against tuberculosis over vaccination with BCG alone.\n          <\/jats:p>","DOI":"10.1128\/iai.72.11.6471-6479.2004","type":"journal-article","created":{"date-parts":[[2004,10,22]],"date-time":"2004-10-22T00:48:03Z","timestamp":1098406083000},"page":"6471-6479","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":84,"title":["Application of Mycobacterial Proteomics to Vaccine Design: Improved Protection by\n            <i>Mycobacterium bovis<\/i>\n            BCG Prime-Rv3407 DNA Boost Vaccination against Tuberculosis"],"prefix":"10.1128","volume":"72","author":[{"given":"Hans Joachim","family":"Mollenkopf","sequence":"first","affiliation":[{"name":"Department of Immunology, Max Planck Institute for Infection Biology, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leander","family":"Grode","sequence":"additional","affiliation":[{"name":"Vakzine Projekt-Management GmbH, Braunschweig"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Mattow","sequence":"additional","affiliation":[{"name":"Department of Immunology, Max Planck Institute for Infection Biology, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Immunology, Max Planck Institute for Infection Biology, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Mann","sequence":"additional","affiliation":[{"name":"Department of Immunology, Max Planck Institute for Infection Biology, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Knapp","sequence":"additional","affiliation":[{"name":"Preclinical Research Vaccines, Chiron Behring GmbH &amp; Co., Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Ulmer","sequence":"additional","affiliation":[{"name":"Chiron Corp., Emeryville, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H. E.","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Department of Immunology, Max Planck Institute for Infection Biology, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.12.6138-6146.2002"},{"key":"e_1_3_2_3_2","first-page":"531","year":"1994","unstructured":"Bloom, B. R., and P. E. Fine. 1994. The BCG experience: implications for future vaccines against tuberculosis, p. 531-557. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection and control. American Society for Microbiology, Washington, D.C.","journal-title":"Tuberculosis: pathogenesis, protection and control"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.2.791-795.2000"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.4.2714-2717.2001"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)09440-3"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/31159"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.10.6227"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.617"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-9792(02)00058-6"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.6.4174-4176.2001"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.1.11"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92348-9"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.93"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.3.1602"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.4.1869"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.18.1.927"},{"key":"e_1_3_2_18_2","first-page":"155","volume":"2","year":"2003","unstructured":"Hakenberg, J., A. K. Nussbaum, H. Schild, H. G. Rammensee, C. Kuttler, H. G. Holzh\u00fctter, P. M. Kloetzel, S. H. E. Kaufmann, and H. J. Mollenkopf. 2003. MAPPP: MHC class I antigenic peptide processing prediction. Appl. Bioinform.2:155-158.","journal-title":"Appl. Bioinform."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.18738-0"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.9.7524-7532.1999"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.14.7187-7202.2002"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0896-893"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1999.01549.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.4.1702-1707.1999"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/35095558"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/79631"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200211080-00005"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/515613"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/1522-2683(200108)22:14<2936::AID-ELPS2936>3.0.CO;2-S"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm881"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.2.681-686.2001"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00109-8"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/422394"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(02)58093-9"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00771-5"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00540-X"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200006)30:6<1724::AID-IMMU1724>3.0.CO;2-A"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.5.2773-2778.2001"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-4310(99)01594-4"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.3.1410-1416.2002"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1997.tb00999.x"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.9.4901-4907.2003"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2003.01589.x"},{"key":"e_1_3_2_44_2","first-page":"200","volume":"2","year":"1998","unstructured":"Sterne, J. A. C., L. C. Rodrigues, and I. N. Guedes. 1998. Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung Dis.2:200-207.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_45_2","first-page":"10147","volume":"76","year":"2002","unstructured":"Tang, Y. Y., F. Villinger, S. I. Staprans, R. R. Amara, J. M. Smith, J. G. Herndon, and H. L. Robinson. 2002. Slowly declining levels of viral RNA and DNA in DNA\/recombinant modified vaccinia virus Ankara-vaccinated macaques with controlled simian-human immunodeficiency virus SHIV-89.6P challenges. J. Virol.76:10147-10154.","journal-title":"6P challenges. J. Virol."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.5.3041-3047.2001"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0896-888"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00255-1"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1135(03)00046-4"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5388.476"},{"key":"e_1_3_2_51_2","unstructured":"World Health Organization. 2002. The World Health Report 2002. Reducing risks promoting healthy life. Report. World Health Organization Geneva Switzerland."}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.72.11.6471-6479.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.72.11.6471-6479.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T04:13:04Z","timestamp":1646453584000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.72.11.6471-6479.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1128\/IAI.72.11.6471-6479.2004"],"URL":"https:\/\/doi.org\/10.1128\/iai.72.11.6471-6479.2004","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"2004-05-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-08-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}